Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis

Autor: Ruth Knuechel, Andreas Boesl, Peter A. Fasching, Matthias W. Beckmann, Michael F. Press, Arno Dimmler, Nuran Bektas Serce, Arndt Hartmann, Jalid Sehouli, Sonja von Serenyi, Irina Klaman, Edgar Dahl, Erik Noetzel
Jazyk: angličtina
Rok vydání: 2013
Předmět:
SERBP1
Pathology
medicine.medical_specialty
Cancer Research
Medizinische Fakultät -ohne weitere Spezifikation
Blotting
Western
Breast Neoplasms
Kaplan-Meier Estimate
Real-Time Polymerase Chain Reaction
uPA/PAI-1
lcsh:RC254-282
Disease-Free Survival
chemistry.chemical_compound
Breast cancer
Prognostic marker
medicine
Biomarkers
Tumor
Genetics
Humans
ddc:610
skin and connective tissue diseases
In Situ Hybridization
Proportional Hazards Models
Tissue microarray
business.industry
Reverse Transcriptase Polymerase Chain Reaction
Cancer
RNA-Binding Proteins
medicine.disease
Prognosis
lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Immunohistochemistry
chemistry
Oncology
Tissue Array Analysis
Plasminogen activator inhibitor-1
Cancer research
Female
Gene expression
Ovarian cancer
Breast carcinoma
business
Plasminogen activator
Fibrinolytic agent
Research Article
Zdroj: BMC cancer 12, 597 (2012). doi:10.1186/1471-2407-12-597
BMC Cancer, Vol 12, Iss 1, p 597 (2012)
BMC Cancer
ISSN: 1471-2407
DOI: 10.1186/1471-2407-12-597
Popis: BMC cancer 12, 597 (2012). doi:10.1186/1471-2407-12-597
Published by BioMed Central [u.a.], London
Databáze: OpenAIRE
Externí odkaz: